Home » Topics » BioWorld Science

BioWorld Science
RSS

CTI amends pacritinib study protocol following end of phase IIa meeting with FDA

July 19, 2019

New CD73 inhibitors identified by Abbisko Therapeutics

July 19, 2019

Adlai Nortye describes IDO1 inhibitors

July 19, 2019

Sunshine Lake Pharma identifies AOC3 inhibitors

July 19, 2019

Medshine Discovery presents new compounds for tuberculosis

July 19, 2019

Bionomics divulges SCN9A blockers for pain

July 19, 2019

Phase IIa data for NA-831 in patients with MCI and mild and moderate Alzheimer's disease presented

July 19, 2019

Minimal radiation exposure to staff seen with Iomab-B in phase III SIERRA trial

July 19, 2019

Phase I plans for NTRX-07, a highly selective and potent CB2 receptor agonist

July 19, 2019

Phase I study of Novo Nordisk's NNC-0247-0829 begins

July 19, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...